VANCOUVER, British Columbia, May 11, 2011 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) announced today the initiation of its first Transcend therapeutic development program directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback